[HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]
[HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]
[China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results Revenue Increases 23.8% to RMB71.7 Million RMB17.6 Million Net Income Attributable to Shareholders Conference Call to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s leading provider of cord blood collection, laboratory]
[China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results Revenue Increases 23.8% to RMB71.7 Million RMB17.6 Million Net Income Attributable to Shareholders Conference Call to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), China’s leading provider of cord blood collection, laboratory]
[Chinard Bloodrporation Reports First Quarter Fiscal 2011 Financial Results Revenuereases 23.8% to RMB71.7 Million RMB17.6 Million Netome Attributable to Shareholdersnferencell to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 Chinard Bloodrporation (NYSE:) (CCBC or thempany), Chinas leading provider ofrd bloodllection, laboratory testing, hematopoietic stem cell processing, and stem cell]
[Chinard Bloodrporation Reports First Quarter Fiscal 2011 Financial Results Revenuereases 23.8% to RMB71.7 Million RMB17.6 Million Netome Attributable to Shareholdersnferencell to be Held at 8am ET September 10, 2010 HONG KONG, China, September 10, 2010 Chinard Bloodrporation (NYSE:) (CCBC or thempany), Chinas leading provider ofrd bloodllection, laboratory testing, hematopoietic stem cell processing, and stem cell]
[(Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G21107100 (CUSIP Number) September 1, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) þ Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the]
[(Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G21107100 (CUSIPNumber) September 1, 2010 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) Rule 13d-1(c) o Rule 13d-1(d) *The remainder of thisver page shall be filled out for a reporting person's initial filing on this form with respect]
[Mitchell S. Nussbaum LLP of Loeb & Loeb 345 Park Avenue New York, NY 10154-1895 Direct Main Fax 212.407.4990 mnussbaum@loeb.com VIA EDGAR August 31, 2010 Tia Jenkins 100 F. Street, N.E. Re: China Cord Blood Corporation Form 20-F for the Year Ended March 31, 2010 Filed July 16, 2010 File No. 001-34541 Dear Ms. Jenkins: China Cord Blood Corporation, a]
[Mitchell S. Nussbaum LLP of Loeb & Loeb 345 Park Avenue New York, NY 10154-1895 Direct Main Fax 212.407.4990 mnussbaum@loeb.com VIA EDGAR August 31, 2010 Tia Jenkins 100 F. Street, N.E. Re: China Cord Blood Corporation Form 20-F for the Year Ended March 31, 2010 Filed July 16, 2010 File No. 001-34541 Dear Ms. Jenkins: China Cord Blood Corporation, a]
